For example, a previous study indicated that E2, FSH, and LH were lower after leuprorelin three- or 6-month depot plus tamoxifen in premenopausal women with HR+ breast cancer (Kurebayashi et al., 2017). This evidence concerns the gene PLOD1 and breast carcinoma.